Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Operations: 2009-2025

Historic Cash from Operations for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$1.4 million.

  • Rockwell Medical's Cash from Operations fell 131.74% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 164.81%. This contributed to the annual value of $4.2 million for FY2024, which is 144.65% up from last year.
  • Latest data reveals that Rockwell Medical reported Cash from Operations of -$1.4 million as of Q3 2025, which was down 173.07% from $1.9 million recorded in Q2 2025.
  • Rockwell Medical's Cash from Operations' 5-year high stood at $4.3 million during Q3 2024, with a 5-year trough of -$12.5 million in Q1 2021.
  • Its 3-year average for Cash from Operations is -$746,364, with a median of -$1.4 million in 2025.
  • Its Cash from Operations has fluctuated over the past 5 years, first tumbled by 240.56% in 2023, then spiked by 2,111.63% in 2024.
  • Rockwell Medical's Cash from Operations (Quarterly) stood at -$9.0 million in 2021, then spiked by 98.76% to -$112,000 in 2022, then spiked by 61.61% to -$43,000 in 2023, then surged by 2,111.63% to $865,000 in 2024, then crashed by 131.74% to -$1.4 million in 2025.
  • Its Cash from Operations was -$1.4 million in Q3 2025, compared to $1.9 million in Q2 2025 and -$3.5 million in Q1 2025.